Design,synthesis, and biological evaluation of novel 3-pyrrolo[b]cyclohexylene-2-dihydroindolinone derivatives as potent receptor tyrosine kinase inhibitors

A novel series of 3-pyrrolo[b]cyclohexylene-2-dihydroindolinone derivatives targeting VEGFR-2, PDGFR-β and c-Kit kinases were designed and synthesized. The molecular design was based on the SAR features of indolin-2-ones as kinase inhibitors. SAR study of the series allowed us to identify compounds possessing more potent inhibitory activities against the three kinases than sunitinb with IC₅₀ values in the low nanomolar range in vitro. Additionally, some compounds also showed favorable antiproliferative activities against a panel of cancer cell lines (BXPC-3, T24, BGC, HEPG2 and HT29).     

Synthesis and antimicrobial activity of polyhalobenzonitrile quinazolin-4(3H)-one derivatives

A novel series of polyhalobenzonitrile quinazolin-4(3H)-one derivatives were synthesized and characterized by NMR, IR, MS, and HRMS spectra. All of the newly prepared compounds were screened for antimicrobial activities against four strains of bacteria (Gram-positive bacterial: Staphylococcus aureus and Bacillus cereus; Gram-negative bacterial: Escherichia coli and Pseudomonas aeruginosa) and one strain of fungi (Candida albicans). Among the synthesized compounds, 5-(dimethylamino)-8-(2,4,5-trichloro-isophthalonitrile) quinazolin-4(3H)-one (7k) exhibited significant activity towards Gram-positive bacterial, Gram-negative bacterial, and the fungi strains. The MIC (0.8–3.3 μg/mL) and MBC (2.6–7.8 μg/mL) for this compound were close to those of nofloxacin, chlorothalonil, and fluconazole, making it the most potent antimicrobial agents in the series.     

Discovery and optimization of orally active cyclohexane-based prolylcarboxypeptidase (PrCP) inhibitors

The synthesis, SAR, binding affinities and pharmacokinetic profiles are described for a series of cyclohexane-based prolylcarboxypeptidase (PrCP) inhibitors discovered by high throughput screening. Compounds show high levels of ex vivo target engagement in mouse plasma 20 h post oral dose.     

Synthesis and pharmacological evaluation of novel bisindolylalkanes analogues

In an effort to develop potent anti-cancer chemopreventive agents that act on topoisomerase II, a novel series of bisindolylalkanes analogues such as 3,3′-(thiochroman-4,4-diyl)bis(1H-indole) are synthesized. Structures of all compounds are elucidated by ¹H NMR, ¹³C NMR and HRMS. Anti-proliferative activities for all of these compounds are investigated by the method of MTT assay on 7 human cancer lines. Most of them showed antitumor activities in vitro, the half maximal inhibitory concentration (IC₅₀) value is 7.798 μg/mL of 3a against MCF7. Compound 3a showed comparable topoisomerase II inhibitory activity to etoposide (VP-16) at 100 μM concentration. The rest of the compounds also showed varying degree topoisomerase II inhibitory activity.     

Exploring pyrimidine-substituted curcumin analogues: Design,synthesis and effects on EGFR signaling

Epidermal growth factor receptor (EGFR) is an effective molecular target of anti-cancer therapies. Curcumin inhibits cancer cell growth in vitro by suppressing gene expression of EGFR and reduces tumor growth in various animal models. To overcome instable and insoluble properties of curcumin as therapeutics, we designed and synthesized six novel pyrimidine-substituted curcumin analogues with or without a hydroxyl group originally present in curcumin. The cell viability tests indicated that IC₅₀ of the analogues containing hydroxyl group were 3 to 8-fold lower than those of the analogues without hydroxyl group in two colon cancer cell lines tested. Western blot analysis indicates the analogues containing hydroxyl group inhibited expression and tyrosine phosphorylation of EGFR. Further protein analyses showed that the analogues had anti-cellular proliferation, pro-apoptosis, and cell cycle arrest properties associated with suppressed EGFR expression. These results indicate that the hydroxyl groups in curcumin and the analogues were critical for observed biological activities.     

黄土高原南麓县域耕地土壤速效养分时空变异

在生态脆弱的黄土高原南麓合阳县,以1983、2006年耕地土壤速效氮、磷、钾含量为对象,利用空间自相关、变异函数及分形维数等方法,研究县域土壤速效养分时空变异特征及主要影响因素.结果表明,从1983到2006年,除土壤速效钾外,耕地速效氮、磷的平均含量分别提高73.98％和92.69％;土壤速效养分全局Moran's I指数和空间相关距均呈递减变化、分维数增加,预示其空间结构减弱,随机变异性增强.土壤速效氮、磷含量在绝大部分研究区域内呈现不同程度累积,而速效钾含量则在59.65％的耕地上减少;导致其不同变化的因素有耕地利用方式、施肥管理、灌溉、土壤类型等,其中以土地利用方式和施肥管理措施的影响最大.     

广西马山岩溶植被年龄序列的群落特征

石漠化地区是我国西南植被恢复和生态重建的重点和难点地区。通过对马山县岩溶植被年龄序列(石漠、草丛、灌丛、小乔林和成熟林)5个演替阶段15个样地(20 m×50 m)的系统取样调查,研究了停止人为干扰后岩溶植被的更新、演替及群落特征的变化。结果表明:沿石漠、草丛、灌丛、小乔林、成熟林的顺向演替发展,群落各层次的覆盖度存在显著差异(P<0.05),乔木层覆盖度以成熟林最大,灌木层覆盖度以小乔林最高,而草本层覆盖度以灌丛最高;重要值≥10.00的科、属、种最大值出现在小乔林;不同演替阶段群落不同层次的结构明显不同,乔木层的植物密度存在显著差异(P<0.05),以小乔林最高;成熟林灌木层的植物密度显著低于小乔林和草丛(P<0.05),与石漠和灌丛差异不显著(P>0.05);森林阶段草本层的植物密度显著低于灌丛、草丛和石漠(P<0.05);群落的物种丰富度随着顺向演替发展而增加,但不同演替阶段不同层次的丰富度变化不同,草本层的物种丰富度以草丛阶段最大,成熟林最小;灌木层的丰富度以小乔林阶段最大,石漠阶段最小;乔木层的丰富度以小乔林最大,成熟林有所下降;不同演替阶段群落草本层的生态优势度无显著差异(P>0.05),而灌木层和乔木层均存在显著差异(P<0.05)。岩溶植被恢复可分为恶劣物理环境阈值和顶极种缺乏的阈值两个阶段,每一个阶段内由不同功能特征的驱动种和关键种决定着群落的演替方向和速度,越接近演替后期,顶极种越丰富,群落驱动种和关键种向高级、大型和长寿植物发展的趋势越明显。     

耕作措施对土壤水热特性和微生物生物量碳的影响

通过山西寿阳设置的8a田间定位试验,比较了全量秸秆还田、免耕覆盖和常规耕作3种耕作措施下土壤含水量、温度及土壤微生物生物量碳变化.结果表明:免耕覆盖与全量还田处理显著提高土壤含水量,与常规耕作相比表层土壤体积含水量在玉米苗期、拔节期、灌浆期和成熟期分别高出18％、22％、29％、21％和3％、10％、12％、13％,具有保水保墒的作用.在苗期不同耕作措施对土壤温度的影响达到显著水平,5 cm处免耕覆盖、全量还田与常规耕作处理土壤温度依次为:18.12、18.76和19.44℃,免耕覆盖和全量还田处理平均温度比常规耕作分别低1.32℃和0.69℃.土壤微生物量碳在整个生育期动态变化是首先迅速上升在玉米生育高峰期(拔节期)达到最高峰,然后开始下降,成熟期趋于平缓.免耕覆盖与全量还田处理下玉米各生育期土壤表层微生物量碳显著高于常规耕作,在苗期、拔节期、灌浆期和成熟期分别比常规耕作高出70％、40％、85％和30％和10％、20％、15％和15％.土壤微生物量碳与土壤温度和土壤含水量相关和极相关.     

应用纤维素结合域标签构建谷氨酸棒状杆菌表达系统

为优化谷氨酸棒状杆菌表达系统的纯化工艺,合成里氏木霉的CBD基因,将其与谷氨酸棒状杆菌分泌表达载体pXMJ19-sp连接,构建以CBD为纯化标签的重组载体pXMJ 19-sp-CBD.在该载体中插入GFP基因并转化至谷氨酸棒状杆菌,可获得分泌表达融合蛋白GFP-CBD的重组菌.该菌经IPTG诱导后的发酵液在紫外灯下显示强烈的绿色荧光,重组蛋白的分泌表达量达200 mg/L.利用CBD标签对纤维素柱的可逆性吸附,可直接对谷氨酸棒状杆菌分泌到培养基中的重组蛋白进行纯化,从而简化工艺和降低成本,为工业化大生产奠定基础.